Octalfa appeared to be the VC, which was created in 2007. The main department of described VC is located in the u00c9cully. The venture was found in Europe in France.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Octalfa, startups are often financed by Sham Innovation Santu00e9, Pertinence Invest, KREAXI. The meaningful sponsors for the fund in investment in the same round are Sham Innovation Santu00e9, Rhone-Alpes Creation, KREAXI. In the next rounds fund is usually obtained by Sham Innovation Santu00e9, Bpifrance, Sofimac Partners.
The top activity for fund was in 2010. The increased amount of exits for fund were in 2019. Considering the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations. This Octalfa works on 0 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
We also calculated 2 valuable employees in our database.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most popular portfolio startups of the fund, we may highlight Orega Biotech, Glycode, NightSwapping. The fund has specific favorite in a number of founders of portfolio startups.
Related Funds
Funds with similar focus
Fund Name | Location |
Arkea Capital Investissement | France, Ile-de-France, Paris |
BnkToTheFuture | China, Hong Kong, Hong Kong Island |
Bravo Equity Partners | - |
Bridgewest Group | California, San Diego, United States |
C15 Ventures | China, Hong Kong, Hong Kong Island |
Gemcorp | England, London, United Kingdom |
Gen Z Ventures | - |
GETTYLAB | California, San Francisco, United States |
Goldrock Media LLC | New York, New York, United States |
GU Equity Partners | - |
Hefei Yijun Chuangye Touzi Guanli Youxian Gongsi | Anhui, China, Hefei |
Human Longevity and Performance Impact Venture Fund | - |
ICP | England, London, United Kingdom |
Tanium | Kirkland, United States, Washington |
UBS O'Connor | Chicago, Illinois, United States |
Xinghe Investment | China, Guangdong, Tianjin |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
NightSwapping | $2M | 10 Sep 2014 | Lyon, Auvergne-Rhône-Alpes, France | ||
Mathym | $708K | 30 Jun 2014 | France, Auvergne-Rhône-Alpes, France | ||
e(ye)BRAIN | $3M | 09 Oct 2012 | France, Ile-de-France, France | ||
Orega Biotech | $3M | 22 Nov 2010 | France, Auvergne-Rhône-Alpes, France | ||
Docea Power | $1M | 02 Jun 2010 | France, Auvergne-Rhône-Alpes, France | ||
Glycode | $3M | 18 Jan 2010 | France, New Aquitaine, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
NightSwapping | $2M | 10 Sep 2014 | Lyon, Auvergne-Rhône-Alpes, France | ||
Mathym | $708K | 30 Jun 2014 | France, Auvergne-Rhône-Alpes, France | ||
e(ye)BRAIN | $3M | 09 Oct 2012 | France, Ile-de-France, France | ||
Orega Biotech | $3M | 22 Nov 2010 | France, Auvergne-Rhône-Alpes, France | ||
Docea Power | $1M | 02 Jun 2010 | France, Auvergne-Rhône-Alpes, France | ||
Glycode | $3M | 18 Jan 2010 | France, New Aquitaine, France |